LONDON (AFX) - Provexis PLC said it has entered into a long-term collaboration agreement with Unilever PLC to jointly develop a new concentrated format of its patented Fruitflow heart-health technology for application in Unilever's food product portfolio.

Financial details of the deal were not disclosed.

The partners plan to enter into a global licence arrangement for the technology.

Fruitflow is a patented natural extract from tomato which Provexis said has been shown in human trials to reduce the propensity for aberrant blood clotting that is typically associated with cardiovascular disease and which can lead to heart attack or stroke.

In 2005 the market for heart benefit foods was worth 4 bln usd globally, Provexis added.

Considering the growth potential this share has a target of about 8-10p in the medium tern and is a good buy at current levels

As usual, pls do ur own research.

if you are over 65 you can get aspirin for free on the NHS!

speaking from experience are we halifax??

family knowledge, didn't you know?

Snore!!!!

I think PXS is like ALIZYME(AZM). When it reached 250p. I will have to dream. Thw right news will make the stock start moving. The price of 23p will be breached in say 2-3 weeks.

fear this one will crash back to earth when people realise the (still to be proved) health benefits are the same as aspirin.

the problem is not about gettin gthe benefit the problem is what happens to you to gain those benefits. Aspirin has numerous sometimes serious side effects if taken regularly including bleeding. the health benefits have been proven and the trila of the particular application of this against aspirin is being concluded.

this is a long way from crashing back anywhere.

Halifax is obviously bitter and twisted about missing out here! So feels he needs to slag the product off. Never mind.

blanche wrong we have been in and out with a nice profit.

Well done profit is profit they say. Iam here for the long term because i believe they have a gr8t product. gl

i think this share will move might buy some more at 20 when starts to rise again

I'm in but with these pharma stocks : you never know where you are....few of the smaller version ever make any money at all.

Good news for Sirco...............


Warning for healthy aspirin users
Healthy people who take aspirin to prevent heart attacks could be doing more harm than good, experts said.

Many people are thought to take a daily dose of the drug in the hope it will help prevent heart trouble.

But the Aspirin for Asymptomatic Atherosclerosis (AAA) trial found its routine use to prevent vascular problems "cannot be supported".

A recent Lancet study said low-dose aspirin should not routinely be used to prevent heart attacks and strokes.

Professor Peter Weissberg, of the British Heart Foundation which part-funded the latest research, said: "We know that patients with symptoms of artery disease, such as angina, heart attack or stroke, can reduce their risk of further problems by taking a small dose of aspirin each day.

"The findings of this study agree with our current advice that people who do not have symptomatic or diagnosed artery or heart disease should not take aspirin, because the risks of bleeding may outweigh the benefits."

The AAA trial recruited 28,980 men and women aged 50 to 75 years in central Scotland, who were free of clinically evident cardiovascular disease.

The results were presented at the European Society of Cardiology Congress in Barcelona.

Story from BBC NEWS:
http://news.bbc.co.uk/go/pr/fr/-/1/hi/uk/8230048.stm

Published: 2009/08/31 06:19:38 GMT

BBC MMIX

(Duplicated in error)

outlook123 how many people in the study reacted badly to the aspirin dose and how many to the placebo?

halifax: I'm not a medical scientist but, as you must be, please feel free to ask Prof. Weissberg and then kindly let us all know in layman's terms:-

British Heart Foundation email address: internet@bhf.org.uk

British Heart Foundation main telephone number: 020 7554 0000

TIA.

Nice steady rise now to agm. 20p ish

I've sold out at a small profit...sorry, but the reason for this is that I'm not 100% convinced about this....a market cap of 114 million pounds and revenue of 5000...I might be back later....but I think the sp is far too high and will come back down too earth with a bump...will follow from the sidelines...

rf
maybe it will maybe it wont. all phenomenal risers need to have a good "story" to tell to back it up. remember the jatropha tree? maybe this time it will be different, lets hope so.
regards
jkd

Well I'm out...excuse my ignorance but the what tree ?.